FDA.reportPublic FDA data

Flucelvax 2025-2026 vaccine 0.5 ML Prefilled Syringe

RxCUI
2718382
RxNorm name
Flucelvax 2025-2026 vaccine 0.5 ML Prefilled Syringe
Display name
Flucelvax 2025-2026 vaccine 0.5 ML Prefilled Syringe
Full name
Flucelvax 2025-2026 vaccine 0.5 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125408Flucelvax, Flucelvax QuadrivalentInfluenza Vaccine351(a)Disc2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
3513dfb0-4d62-4ad1-bb15-75c7555896ffFlucelvax 2025-2026 vaccine 0.5 ML Prefilled SyringeSY12These highlights do not include all the information needed to use FLUCELVAX ® safely and effectively. See full prescribing information for FLUCELVAX. FLUCELVAX (Influenza Vaccine) Injectable Suspension, for Intramuscular Use 2025-2026 Formula Initial U.S. Approval: 201220260305
3513dfb0-4d62-4ad1-bb15-75c7555896ffFLUCELVAX 2025-2026 vaccine 0.5 ML Prefilled SyringePSN12These highlights do not include all the information needed to use FLUCELVAX ® safely and effectively. See full prescribing information for FLUCELVAX. FLUCELVAX (Influenza Vaccine) Injectable Suspension, for Intramuscular Use 2025-2026 Formula Initial U.S. Approval: 201220260305
3513dfb0-4d62-4ad1-bb15-75c7555896ff0.5 ML influenza A virus A/Georgia/12/2022 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Victoria/800/2024 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax 2025-2026]SBD12These highlights do not include all the information needed to use FLUCELVAX ® safely and effectively. See full prescribing information for FLUCELVAX. FLUCELVAX (Influenza Vaccine) Injectable Suspension, for Intramuscular Use 2025-2026 Formula Initial U.S. Approval: 201220260305
49ddaee7-fd56-ecb9-e063-6294a90a6ed60.5 ML influenza A virus A/Georgia/12/2022 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Victoria/800/2024 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax 2025-2026]SBD1FLUCELVAX (Influenza Vaccine) Injectable Suspension, for Intramuscular Use 2025-2026 Formula Initial U.S. Approval: 201220260202
49ddaee7-fd56-ecb9-e063-6294a90a6ed6Flucelvax 2025-2026 vaccine 0.5 ML Prefilled SyringeSY1FLUCELVAX (Influenza Vaccine) Injectable Suspension, for Intramuscular Use 2025-2026 Formula Initial U.S. Approval: 201220260202
49ddaee7-fd56-ecb9-e063-6294a90a6ed6FLUCELVAX 2025-2026 vaccine 0.5 ML Prefilled SyringePSN1FLUCELVAX (Influenza Vaccine) Injectable Suspension, for Intramuscular Use 2025-2026 Formula Initial U.S. Approval: 201220260202